Company news

Sol-Gel Technologies Ltd. news in 2020

Sol-Gel Technologies Ltd.'s news releases, calls and decks from 2020, newest first.

View company

Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo® for the Treatment of Acne Vulgaris

December 6, 2020

Successful Completion of the COVID-19 Sol-Gel Formulation Development

November 24, 2020

Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update

November 11, 2020

Sol-Gel to Present at Upcoming Healthcare Investor Conferences in November 2020

November 8, 2020

Sol-Gel Technologies to Report Third Quarter 2020 Financial Results on November 12, 2020

November 3, 2020

Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay® for the Treatment of Inflammatory Lesions of Rosacea

September 9, 2020

Sol-Gel to Present at Upcoming Healthcare Investor Conferences in September

September 7, 2020

Sol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobrii®

September 2, 2020

Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update

August 5, 2020

Sol-Gel Technologies to Report Second Quarter 2020 Financial Results on August 6, 2020

July 28, 2020

Sol-Gel Technologies Partnered Generic Product Expected to Launch in the Second Quarter of 2021

July 27, 2020

Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates

June 28, 2020

Sol-Gel to Present at Virtual BMO 2020 Prescriptions for Success Healthcare Conference

June 15, 2020

Sol-Gel to Present at Upcoming Healthcare Investor Conferences

May 26, 2020

Sol-Gel Technologies Reports First Quarter 2020 Financial Results and Corporate Update

May 13, 2020

Sol-Gel Technologies to Report First Quarter 2020 Financial Results and Company Updates on May 14, 2020

May 6, 2020

Sol-Gel Technologies Announces Closing of Additional $5.0 Million Investment

April 12, 2020

Sol-Gel Technologies to Present at Upcoming 2020 Solebury Trout Virtual Investor Conference

March 24, 2020

Sol-Gel Technologies Reports Full Year 2019 Financial Results and Corporate Update

March 23, 2020

Sol-Gel Technologies to Report Full Year 2019 Financial Results and Corporate Update

March 18, 2020

Sol-Gel to Present at the Cowen 40th Annual Health Care Conference

February 18, 2020

Sol-Gel Announces Pricing of Public Offering of Ordinary Shares and Warrants to Purchase Ordinary Shares

February 13, 2020

Sol-Gel Announces Positive Topline Results from Open-Label, Long-Term Safety Study of Epsolay® for Treatment up to 52 Weeks

February 12, 2020

Sol-Gel Provides Product Pipeline Updates and Anticipated Milestones for 2020

February 4, 2020

Sol-Gel Announces Presentation of Data for its Topical Product Candidates for Acne and Rosacea at the 16th Annual Maui Derm for Dermatologists 2020 Meeting

January 20, 2020

Sol-Gel Hosts Investor Call to Discuss Positive Results from Twyneo® Phase 3 Program in Acne Vulgaris

January 7, 2020

Sol-Gel Announces Initiation of SGT-210 Phase 1 Proof of Concept Study in Palmoplantar Keratoderma (PPK)

January 1, 2020

Decks in 2020